Navigation Links
Optimizing cell therapy against tumors is a balancing ACT

Adoptive cell transfer (ACT) therapy is used to treat patients with metastatic solid tumors. ACT involves the removal of some of the patient's cancer cells, and some of their immune T cells. When the cells are mixed together, specific parts of the cancer cells that stimulate the T cells to cause an immune attack can be identified. The T cells get expanded and re-infused into the patient to mount an immunological, anti-cancer response against the tumors. One of the challenges faced is selecting the appropriate T cells with proper antigen specificity.

In a new study appearing in the June 1 print issue of The Journal of Clinical Investigation, Nicholas Restifo and colleagues identified which cells are optimal for treating large, vascularized, established tumors. The authors use a mouse model that mimics the human clinical situation. They find that phenotypic and functional qualities of T cells are associated with the ability of ACT to cause regression of large, established melanomas. Seemingly paradoxical, naïve and early effector T cells are more effective for tumor treatment than more differentiated T cells.

In an accompanying commentary, Daniel Speiser and Pedro Romero write, "optimal therapeutic efficacy may depend on different T cell selection and preparation strategies" and these findings indicate that a pragmatic strategy for ACT is to keep the in vitro T cell expansion phase as short as possible to keep them naïve. These findings are important for development of improved adoptive immunotherapy approaches for treating tumors and established infectious diseases.

TITLE: Acquisition of full effector function in vitro paradoxically impairs the in vivo anti-tumor efficacy of adoptively transferred CD8+ T cells

TITLE: Towards improved immunocompetence of adoptively transferred CD8+ T cells


'"/>

Source:Journal of Clinical Investigation


Page: 1

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Columbia research lifts major hurdle to gene therapy for cancer
3. Combination therapy boosts effectiveness of telomere-directed cancer cell death
4. Gene therapy converts dead bone graft to new, living tissue
5. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
8. New therapy for HIV/AIDS eliminates needles and excessive toxicity
9. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
10. Gene therapy for Parkinsons disease moves forward in animals
11. Pulsating ultrasound enhances gene therapy for tumors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/27/2018)... ... November 27, 2018 , ... ... companies have worked together to integrate the LabArchives Classroom Edition with Current Protocols ... offering will be available beginning January of 2019. , The integration ...
(Date:11/20/2018)... (PRWEB) , ... November 19, 2018 , ... ... Emsculpt in the Bay Area -- the first and only non-invasive buttock lift ... Emsculpt is FDA cleared to strengthen, tone and firm the buttocks to provide ...
(Date:11/16/2018)... (PRWEB) , ... November 16, 2018 , ... ... P.G., was awarded the International Bottled Water Association’s (IBWA’s) IBWA/Shayron Barnes-Selby Advocacy ... , IBWA’s Advocacy Award, named “The Selby” after longtime IBWA contributor Shayron Barnes-Selby, ...
Breaking Biology News(10 mins):
(Date:11/20/2018)... ... ... year Forbes receives thousands of nominations for candidates wishing to be selected for its ... of age. The Forbes 30 Under 30 list showcases the top 30 individuals in ... , In 2017, Visikol CEO Dr. Michael Johnson was named to the Forbes ...
(Date:11/13/2018)... ... November 12, 2018 , ... ... contamination that two large U.S. studies, published last week, confirm pose a significant ... of Infection Control (AJIC) conclude that stethoscopes are often improperly or rarely disinfected. ...
(Date:11/13/2018)... ... November 13, 2018 , ... Sharon Kleyne, founder and new ... Pass, Oregon believes in the power of talk radio education Power of Water® ... the Power of Water® on talk radio every week with the “Sharon Kleyne ...
(Date:11/9/2018)... ... November 08, 2018 , ... Superior ... and IT solutions with 140 employees on both the east and west coasts, ... the Pennsylvania Convention Center on November 14 and 15 in Philadelphia. The event ...
Breaking Biology Technology: